[Federal Register Volume 62, Number 96 (Monday, May 19, 1997)]
[Notices]
[Pages 27280-27281]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-13079]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated February 6, 1997, and published in the Federal 
Register on February 21, 1997, (62 FR 8041), Noramco of Delaware, Inc., 
Division of McNeilab, Inc., 500 Old Swedes Landing Road, Wilmington, 
Delaware 19801, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of the 
basic classes of controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule         
------------------------------------------------------------------------
Codeine (9050).............................  II                         
Oxycodone (9143)...........................  II                         
Hydrocodone (9193).........................  II                         
Morphine (9300)............................  II                         
Thebaine (9333)............................  II                         
------------------------------------------------------------------------

    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Noramco of Delaware, Inc. to 
manufacture the listed controlled

[[Page 27281]]

substances is consistent with the public interest at this time. 
Therefore, pursuant to 21 U.S.C. Sec. 823 and 23 CFR Secs. 0.100 and 
0.104, the Acting Deputy Assistant Administrator, Office of Diversion 
Control, hereby orders that the application submitted by the above firm 
for registration as a bulk manufacturer of the basic classes of 
controlled substances listed above is granted.

    Dated: May 6, 1997.
Terrance W. Woodworth,
Acting Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration.
[FR Doc. 97-13079 Filed 5-16-97; 8:45 am]
BILLING CODE 4410-09-M